Nexus wins patent litigation for injectable cyclophosphamideClophosphamide has been approved for certain kinds of cancer. Meitheal Pharmaceuticals releases generic AbraxanePaclitaxel is indicated for the treatment of metastatic breast cancer, metastatic adenocarcinoma of the pancreas and locally advanced or metastatic non-small cell lung cancer. FDA grants interchangeability designation for Humira biosimilar to Samsung Bioepis, Organon Hadlima is now interchangeable with all presentations of Humira. Avenacy launches doxycycline for injection Doxycycline for injection is a broad-spectrum antibiotic indicated for the treatment of certain infections caused by susceptible bacteria. Celltrion's Humira biosimilar receives FDA interchangeability designation Yuflyma is now fully interchangeable with the reference product, Humira (adalimumab), across all marketed dosage forms and strengths. Amneal releases generic Byetta Exenatide is a glucagon-like peptide-1 agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus. Alembic launches generic Xarelto Rivaroxaban tablets are a factor Xa inhibitor indicated to reduce risk of stroke and systemic embolism in nonvalvular atrial fibrillation. Fresenius Kabi releases epinephrine injection in new dosage strength Epinephrine injection is used for emergency treatment of allergic reactions and in patients with hypotension associated with septic shock. Sandoz launches Pyzchiva autoinjector in Europe This is the first ustekinumab biosimilar in Europe commercially available in an autoinjector. Nexus launches methylene blue injection Methylene blue injection is indicated for the treatment of methemoglobinemia—a condition that affects the blood’s ability to carry oxygen. 1 2 3 4 5 Next Last
